Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
1.850
+0.020 (1.09%)
At close: Dec 31, 2025, 4:00 PM EST
1.840
-0.010 (-0.55%)
After-hours: Dec 31, 2025, 6:22 PM EST
Nkarta Market Cap
Nkarta has a market cap or net worth of $131.4 million as of December 31, 2025. Its market cap has decreased by -20.42% in one year.
Market Cap
131.40M
Enterprise Value
-73.94M
1-Year Change
-20.42%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $131.40M, a decrease of -91.03%. That is a compound annual growth rate of -35.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |